140 related articles for article (PubMed ID: 38129557)
1. Development of a ferroptosis-based molecular markers for predicting RFS in prostate cancer patients.
Chen J; Zhang L; Luo Y; Tan C; Hu H; Jiang Y; Xi N; Zeng Q; Peng H
Sci Rep; 2023 Dec; 13(1):22804. PubMed ID: 38129557
[TBL] [Abstract][Full Text] [Related]
2. A Novel Ferroptosis-Based Molecular Signature Associated with Biochemical Recurrence-Free Survival and Tumor Immune Microenvironment of Prostate Cancer.
Ke ZB; You Q; Sun JB; Zhu JM; Li XD; Chen DN; Su L; Zheng QS; Wei Y; Xue XY; Xu N
Front Cell Dev Biol; 2021; 9():774625. PubMed ID: 35071228
[No Abstract] [Full Text] [Related]
3. Construction and analysis of a novel ferroptosis-related gene signature predicting prognosis in lung adenocarcinoma.
Zhou J; Wang X; Li Z; Jiang R
FEBS Open Bio; 2021 Nov; 11(11):3005-3018. PubMed ID: 34499810
[TBL] [Abstract][Full Text] [Related]
4. Construction and validation of a novel ferroptosis-related prognostic signature for lung adenocarcinoma.
Yang L; Fan X; Zhou C; Wang Z; Cui Z; Wu X; Xu Z; Yang J; Zhang X
Transl Lung Cancer Res; 2023 Aug; 12(8):1766-1781. PubMed ID: 37691861
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genes.
Diao X; Guo C; Liu L; Wang G; Li S
Thorac Cancer; 2021 Dec; 12(23):3236-3247. PubMed ID: 34672420
[TBL] [Abstract][Full Text] [Related]
6. A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer.
Liang Y; Ye F; Xu C; Zou L; Hu Y; Hu J; Jiang H
BMC Cancer; 2021 Aug; 21(1):943. PubMed ID: 34418989
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of a ferroptosis-related gene signature for predicting survival in skin cutaneous melanoma.
Ping S; Wang S; Zhao Y; He J; Li G; Li D; Wei Z; Chen J
Cancer Med; 2022 Sep; 11(18):3529-3541. PubMed ID: 35373463
[TBL] [Abstract][Full Text] [Related]
8. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma.
Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J
Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889
[TBL] [Abstract][Full Text] [Related]
9. Identification of a ferroptosis-related gene signature (FRGS) for predicting clinical outcome in lung adenocarcinoma.
Wang S; Wu C; Ma D; Hu Q
PeerJ; 2021; 9():e11233. PubMed ID: 33954048
[TBL] [Abstract][Full Text] [Related]
10. Identification of immunity- and ferroptosis-related genes for predicting the prognosis of serous ovarian cancer.
Yuan X; Zhou Q; Zhang F; Zheng W; Liu H; Chen A; Tao Y
Gene; 2022 Sep; 838():146701. PubMed ID: 35777713
[TBL] [Abstract][Full Text] [Related]
11. Construction of A Novel Ferroptosis-related Prognostic Risk Signature for Survival Prediction in Clear Cell Renal Cell Carcinoma Patients.
Tang F; Zhang J; Zhu L; Lai Y; Li Z; Lu Z; Tang Z; Mai Y; Huang R; He Z
Urol J; 2022 May; 19(4):289-299. PubMed ID: 35598038
[TBL] [Abstract][Full Text] [Related]
12. Identification of the ferroptosis-related long non-coding RNAs signature to improve the prognosis prediction and immunotherapy response in patients with NSCLC.
Li M; Zhang Y; Fan M; Ren H; Chen M; Shi P
BMC Med Genomics; 2021 Dec; 14(1):286. PubMed ID: 34861872
[TBL] [Abstract][Full Text] [Related]
13. Identification of a Novel Ferroptosis-Related Gene Prognostic Signature in Bladder Cancer.
Sun J; Yue W; You J; Wei X; Huang Y; Ling Z; Hou J
Front Oncol; 2021; 11():730716. PubMed ID: 34557413
[TBL] [Abstract][Full Text] [Related]
14. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of a ferroptosis-related signature for prediction of the prognosis and tumor microenvironment in patients with chromophobe renal cell carcinoma.
Liu S; Yao Y; Hou M; Mei J; Sun L; Zhang G
BMC Cancer; 2023 Nov; 23(1):1079. PubMed ID: 37940859
[TBL] [Abstract][Full Text] [Related]
16. Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients.
Li H; Zhang X; Yi C; He Y; Chen X; Zhao W; Yu D
BMC Cancer; 2021 Jul; 21(1):835. PubMed ID: 34284753
[TBL] [Abstract][Full Text] [Related]
17. A Novel Prognosis Signature Based on Ferroptosis-Related Gene DNA Methylation Data for Lung Squamous Cell Carcinoma.
Wang X; Meng Y; Liu C; Yang H; Zhou S
J Oncol; 2022; 2022():9103259. PubMed ID: 36131791
[TBL] [Abstract][Full Text] [Related]
18. A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer.
Yang L; Li C; Qin Y; Zhang G; Zhao B; Wang Z; Huang Y; Yang Y
Front Oncol; 2021; 11():686044. PubMed ID: 34422642
[TBL] [Abstract][Full Text] [Related]
19. Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma.
Xu L; Zheng Q; Liu W
BMC Cancer; 2022 Mar; 22(1):229. PubMed ID: 35236323
[TBL] [Abstract][Full Text] [Related]
20. Identification of a prognostic signature based on five ferroptosis-related genes for diffuse large B-cell lymphoma.
Li W; Yao R; Yu N; Zhang W
Cancer Biomark; 2024 Mar; ():. PubMed ID: 38517778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
